Identifying and Treating Familial Hypercholesterolemia

Details & Video

Program Time: 30 minutes
Accreditation-CME Credits: This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 0.5 Mainpro+ credits.
Target Audience: General Practitioners
Program available until: September 25, 2019
Program Preview
Click image above to play the program preview.
To watch the full program, please login or register

Overview & Objectives

Identifying and Treating Familial Hypercholesterolemia

Target Audience: General Practitioners.

By participating in this educational program, health care providers will be able to:
  1. Examine the prevalence and risk associated with FH
  2. Review the strategies to recognize potential FH patients
  3. Identify optimal treatment strategies for FH



Accreditation

This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 0.5 Mainpro+ credits.

This program was supported in part by educational funding from Amgen Canada.

Claiming your credits: Please submit your credits for this activity online at www.cfpc.ca/login. Please retain proof of your participant for six (6) years in case you are selected to participate in credit validation or auditing.

Planning Committee & Faculty

Planning Committee & Faculty

Milan Gupta
Milan Gupta
MD, FRCPC, FCCS

Associate Clinical Professor of Medicine,
McMaster University

Medical Director
Canadian Collaborative Research Network

View disclosures

Brampton, ON
Jeffrey Habert
Jeffrey Habert
MD, CCFP, FCFP

Assistant Professor,
University of Toronto,
Dept. of Family and Community Medicine

View disclosures

Toronto, Ontario
Daniel Ngui
Daniel Ngui
BSc (P.T), MD, CFPC, FCFP

Clinical Associate Professor
University of British Columbia

Medical Director
Fraser Street Medical

View disclosures

Vancouver, ON
Marla Shapiro
Marla Shapiro
C.M., MDCM, CCFP, MHSc, FRCPC, FCFP, NCMP

Professor, University of Toronto
Department of Family and Community Medicine

University Health Network
North York General, Mount Sinai

View disclosures

Toronto, Ontario
Rob Hegele
Faculty
Rob Hegele
MD, FRCPC, FACP, FAHA, FCAHS, FCCS

Jacob J. Wolfe Distinguished Medical Research Chair in Human Gene Function
Martha G. Blackburn Chair in Cardiovascular Research
Director, London Regional Genomics Centre
Scientist, Molecular Medicine, Robarts Research Institute
Distinguished University Professor, Departments of Medicine (Division of Endocrinology) and Biochemistry, Western University
View disclosures

London, Ontario

Agenda

Agenda

Program ChapterDuration
(Min:Sec)
Introduction2:02
Patient case5:34
Prevalence of FH4:39
Associated CV risk4:03
Identifying potential FH patient2:29
Treatment strategies4:31
Practical considerations and summary2:08


Sponsorship

CCRN sm

This program has been developed by the Canadian Collaborative Research Network, a not-for-profit physician organization, and is supported through an educational grant received from:

Amgen Canada

Links & Resources

Links & Resources:

  • Yuan et al. CMAJ 2006; 174:1124-9
  • Adapted from Nordestgaard BG et al. Eur Heart J 2013;34:3478-90a
  • Adapted from Austin MA et al. Am J Epidemiol 2004;160:421-9; Genest J et al. Can J Cardiol 2014;30:1471-81
  • Ruel, I et al. in review
  • Genest J. et al. Can J Cardiol. 2014; 30:1471-81
  • Defesche JC et al. Nat. Rev. Dis. Primers 2017 doi:10.1038/nrdp.2017.93
  • Adapted from Kastelein, JJP et al. As presented during ESC Congress 2015, Abstract 5772.
  • Raal F et al. Lancet 2015;385:331-40